Disease free survival rate with dose dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and pertuzumab (ddACTHP) in patients with HER2-positive early stage breast cancer: A single institution experience Meeting Abstract
| Authors: | Singh, J. C.; Patil, S.; Norton, L.; Robson, M.; Dang, C. |
| Abstract Title: | Disease free survival rate with dose dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and pertuzumab (ddACTHP) in patients with HER2-positive early stage breast cancer: A single institution experience |
| Meeting Title: | 42nd Annual San Antonio Breast Cancer Symposium (SABCS) |
| Journal Title: | Cancer Research |
| Volume: | 80 |
| Issue: | 4 Suppl. |
| Meeting Dates: | 2019 Dec 10-14 |
| Meeting Location: | San Antonio, TX |
| ISSN: | 0008-5472 |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2020-02-01 |
| Language: | English |
| ACCESSION: | WOS:000527012501184 |
| DOI: | 10.1158/1538-7445.Sabcs19-p2-16-10 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: P2-16-10 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
